These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 18473698)

  • 1. The impact of clinical trial design on cost-effectiveness analyses: illustration from a published study of the one-touch ultrasmart blood glucose meter for insulin-using diabetes patients.
    Tunis SL; Minshall ME
    Diabetes Technol Ther; 2008 Jun; 10(3):227-31. PubMed ID: 18473698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.
    Laffel LM; Hsu WC; McGill JB; Meneghini L; Volkening LK
    Diabetes Technol Ther; 2007 Jun; 9(3):254-64. PubMed ID: 17561796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US.
    Tunis SL; Minshall ME
    Curr Med Res Opin; 2010 Jan; 26(1):151-62. PubMed ID: 19919376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of patient experience using a blood glucose meter with an in-built insulin dose calculator.
    Ramtoola S; Jude E; Robinson A; Malik I; Rayman G; Dang C; RossMartin GD; Ali A
    J Diabetes Sci Technol; 2014 Jul; 8(4):776-82. PubMed ID: 24876430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for continuous glucose monitoring: sufficient for reimbursement?
    Heinemann L; DeVries JH
    Diabet Med; 2014 Feb; 31(2):122-5. PubMed ID: 24152416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting health and reducing costs: a role for reform of self-monitoring of blood glucose provision within the National Health Service.
    Leigh S; Idris I; Collins B; Granby P; Noble M; Parker M
    Diabet Med; 2016 May; 33(5):681-90. PubMed ID: 26443548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus.
    Clarke SF; Foster JR
    Br J Biomed Sci; 2012; 69(2):83-93. PubMed ID: 22872934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial.
    Saunders R; Lian J; Karolicki B; Valentine W
    J Med Econ; 2014 Dec; 17(12):827-36. PubMed ID: 25168164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reimbursement for Continuous Glucose Monitoring.
    Heinemann L; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S248-52. PubMed ID: 26784130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information technology and home glucose clamping.
    Albisser AM; En Chao SC; Parson ID; Sperlich M
    Diabetes Technol Ther; 2001; 3(3):377-86. PubMed ID: 11762516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term cost-effectiveness of insulin detemir versus NPH insulin in type 2 diabetes in Sweden.
    Smith-Palmer J; Fajardo-Montañana C; Pollock RF; Ericsson A; Valentine WJ
    J Med Econ; 2012; 15(5):977-86. PubMed ID: 22563742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational use of blood glucose test strips for self-monitoring in patients with diabetes mellitus: Economic impact in the Portuguese healthcare system.
    Risso T; Furtado C
    Diabetes Res Clin Pract; 2017 Dec; 134():161-167. PubMed ID: 28951334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position statement on efficiency of technologies for diabetes management.
    Martín-Vaquero P; Martínez-Brocca MA; García-López JM; ; ;
    Endocrinol Nutr; 2014 Dec; 61(10):e45-63. PubMed ID: 25453400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.
    Fritzen K; Basinska K; Stautner C; Braun KF; Rubio-Almanza M; Nicolucci A; Kennon B; Vergès B; Hosny Y; Schnell O
    J Diabetes Sci Technol; 2020 Mar; 14(2):262-270. PubMed ID: 31387385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sliding-Scale Insulin Use in Long-Term Care: An Updated Perspective.
    Woods J; Nadelson M
    Consult Pharm; 2017 Feb; 32(2):105-108. PubMed ID: 28569662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.